Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BMY 28100

Known as: BMY-28100 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The objective of this Phase I study was to evaluate the safety, tolerance, and pharmacokinetics of BMY-28100 in 36 male subjects… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1990
Highly Cited
1990
The in vitro susceptibilities of 551 community isolates of Streptococcus pneumoniae from the Canadian province of Ontario to… Expand
  • table 1
Is this relevant?
1988
1988
  • R. Jones, A. Barry
  • Diagnostic microbiology and infectious disease
  • 1988
  • Corpus ID: 21992252
The antimicrobial activity of BMY-28100 was tested against approximately 7,000 bacterial pathogens in a multicenter, multiphased… Expand
Is this relevant?
1988
1988
BMY-28100 is a new orally absorbed cephalosporin whose in vitro activity was compared with that of cefaclor. BMY-28100 was more… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
BMY 28100, a new oral cephalosporin with a (Z)-propenyl side chain at the 3 position and a p-hydroxyphenylglycyl substituent at… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
1987
1987
The activity of BMY-28100, a new orally administered cephalosporin, was compared with those of cephalexin and cefaclor. BMY-28100… Expand
  • table 1
  • table 2
  • figure 2
Is this relevant?
1987
1987
The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric… Expand
  • table 1
Is this relevant?
1987
1987
  • N. Chin, H. Neu
  • Antimicrobial Agents and Chemotherapy
  • 1987
  • Corpus ID: 35447900
BMY-28100 is a new oral cephalosporin which had in vitro activity superior to that of cephalexin and cefaclor against… Expand
  • table 1
  • table 2
Is this relevant?
1987
1987
The synthesis and structure-activity relationships of 7-[D-alpha-amino-alpha-(4-hydroxyphenyl)-acetamido]-3-[(Z)-1-propenyl]- 3… Expand
Is this relevant?
1987
1987
A new semisynthetic oral cephalosporin, BMY-28100, was evaluated for in vitro and in vivo antibacterial activities in comparison… Expand
Is this relevant?